Q4 2025 Management View CEO Lawrence Bruno highlighted that "Core continued to execute its strategic plan of technology ...

This morning, I am joined by Christopher Scott Hill, Core's Chief Financial Officer, and Gwendolyn Y. Gresham, Core's Senior Vice President and Head of Investor Relations. Gwen will start by making ...

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported net income of $7.1 million in its fourth ...

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago. These ...

Bio-Rad’s BIO Clinical Diagnostics arm continues to gain momentum. The company’s focus on geographic expansion is also encouraging. However, unfavorable macroeconomic conditions continue to weigh ...

Increase in demand for precision medicine, rise in the prevalence of chronic diseases, and advancements in molecular diagnostics technology drive the growth of the global core clinical molecular ...

Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...